Projects per year
Personal profile
Research Area Keywords
- Cancer
- Clinical Care
- Clinical Translation & Trials
Fingerprint
Dive into the research topics where Polly A. Niravath is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 13 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
Phase III_OlanzapineFosaprepitant_Highly Emetogenic Chemotherapy Patients_ALLIANCE A221602
Darcourt, J., Bernicker, E. H., Chang, J. C., Geyer, C. E., Heyne, K., Niravath, P. A. & Randhawa, J.
9/28/20 → …
Project: Clinical Trial
-
A Phase 2, Multicenter, Single-arm Study of Retreatment With Brentuximab Vedotin in Subjects With Relapsed or Refractory Classic Hodgkin Lymphoma (cHL) or CD30-expressing Peripheral T Cell Lymphoma (PTCL)
Pingali, S. R., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Darcourt, J., Heyne, K., Niravath, P. A., Petkova, J., Randhawa, J., Rice, L. & Singh, M.
7/8/20 → …
Project: Clinical Trial
-
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo
Niravath, P. A., Abdelrahim, M., Arentz, C., Chang, J. C., Darcourt, J., Geyer, C. E., Heyne, K. & Singh, M.
6/16/20 → …
Project: Clinical Trial
-
A Phase 2, Multicenter, Open-label, Safety and Efficacy Study of XERMELO® (Telotristat Ethyl) Plus First-line Chemotherapy in Patients With Locally Advanced, Unresectable, Recurrent or Metastatic Biliary Tract Cancer (BTC)
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Darcourt, J., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
4/27/20 → …
Project: Clinical Trial
Research Output
-
Comparison of outcomes between metaplastic and triple-negative breast cancer patients
Polamraju, P., Haque, W., Cao, K., Verma, V., Schwartz, M., Klimberg, V. S., Hatch, S., Niravath, P., Butler, E. B. & Teh, B. S., Feb 2020, In : Breast. 49, p. 8-16 9 p.Research output: Contribution to journal › Article
1 Scopus citations -
TBCRC023: A randomized phase II neoadjuvant trial of lapatinib plus trastuzumab without chemotherapy for 12 versus 24 weeks in patients with HER2-positive breast cancer
on behalf of the Translational Breast Cancer Research Consortium, Feb 15 2020, In : Clinical Cancer Research. 26, 4, p. 821-827 7 p.Research output: Contribution to journal › Article
4 Scopus citations -
Acupuncture and Vitamin D for the Management of Aromatase Inhibitor-Induced Arthralgia
Anand, K. & Niravath, P., Jun 1 2019, In : Current Oncology Reports. 21, 6, 51.Research output: Contribution to journal › Review article
2 Scopus citations -
A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)
Patel, T., Ensor, Jr., J. E., Creamer, S. L., Boone, T., Rodriguez, A. A., Niravath, P. A., Darcourt, J., Meisel, J. L., Li, X., Zhao, J., Kuhn, J. G., Rosato, R. R., Qian, W., Belcheva, A., Schwartz, M. R., Kaklamani, V. G. & Chang, J. C., Sep 2 2019, In : Breast Cancer Research. 21, 1, 100.Research output: Contribution to journal › Article
4 Scopus citations -
Omission of radiation therapy following breast conservation in older (≥70 years) women with T1-2N0 triple-negative breast cancer
Haque, W. M., Verma, V., Hsiao, K. Y., Hatch, S., Arentz, C., Szeja, S., Schwartz, M., Niravath, P. A., Bonefas, E., Miltenburg, D., Butler, E. B. & Teh, B. S., Nov 1 2019, In : Breast Journal. 25, 6, p. 1126-1133 8 p.Research output: Contribution to journal › Article
3 Scopus citations